SUSQUEHANNA INTERNATIONAL GROUP, LLP - TARSUS PHARMACEUTICALS INC ownership

TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TARSUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$627,281
-27.6%
35,300
-26.4%
0.00%
Q2 2023$866,186
+24.8%
47,935
+18.2%
0.00%
Q3 2022$694,000
+73.5%
40,557
+48.0%
0.00%
Q2 2022$400,00027,4000.00%
Other shareholders
TARSUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,417,157$41,069,0003.79%
Vivo Capital, LLC 2,987,331$86,573,0003.75%
Cormorant Asset Management, LP 1,514,269$43,884,0001.49%
Ghost Tree Capital, LLC 170,000$4,927,0001.35%
RTW INVESTMENTS, LP 2,013,601$58,354,0000.88%
COWEN AND COMPANY, LLC 514,289$14,904,0000.78%
Perceptive Advisors 2,592,832$75,140,0000.49%
Altium Capital Management LP 70,573$2,045,0000.47%
TimesSquare Capital Management, LLC 686,705$19,901,0000.16%
Jefferies Group LLC 442,993$12,837,9370.08%
View complete list of TARSUS PHARMACEUTICALS INC shareholders